BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25566593)

  • 1. Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function.
    Ji F; Yang XH; Ai Xing Zi AL; Ha Ni Ke Zi TX; He Y; Ding Y
    Clin Exp Obstet Gynecol; 2014; 41(6):677-80. PubMed ID: 25566593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
    Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
    Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
    Li L; Leng J; Jia S; Lang J
    Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
    Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
    Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
    Sheng J; Lu D; Zhang JP; Cui GF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
    Ishizawa C; Hirota Y; Iida R; Kaku T; Hirata T; Fukui Y; Omura E; Akaeda S; Hiraoka T; Matsuo M; Osuga Y
    Reprod Sci; 2023 Mar; 30(3):966-973. PubMed ID: 36071343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
    Fong YF; Singh K
    Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.
    Lin CJ; Hsu TF; Chang YH; Huang BS; Jiang LY; Wang PH; Chen YJ
    Taiwan J Obstet Gynecol; 2018 Feb; 57(1):47-51. PubMed ID: 29458902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia].
    Li L; Leng JH; Shi JH; Zhang JJ; Jia SZ; Li XY; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):424-30. PubMed ID: 27356477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up.
    Shi JH; Zhu SY; Li XY; Dai Y; Leng JH
    J Gynecol Obstet Hum Reprod; 2023 May; 52(5):102572. PubMed ID: 36914113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.
    Zhang P; Song K; Li L; Yukuwa K; Kong B
    Med Princ Pract; 2013; 22(5):480-3. PubMed ID: 23796720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
    Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
    Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
    Bahamondes L; Petta CA; Fernandes A; Monteiro I
    Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial.
    Zheng J; Xia E; Li TC; Sun X
    J Reprod Med; 2013; 58(7-8):285-90. PubMed ID: 23947077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategies for pelvic pain associated with adenomyosis.
    Radzinsky VE; Khamoshina MB; Nosenko EN; Dukhin AO; Sojunov MA; Orazmuradov AA; Lebedeva MG; Orazov MR
    Gynecol Endocrinol; 2016 Oct; 32(sup2):19-22. PubMed ID: 27759444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E; Wildemeersch P
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):192-8. PubMed ID: 11848648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.